GlassScriptPhysician profile
Taehee Strauss
NPI 1720620487
$5,083.08
in general payments reported to CMS, 2019-2025
19 companies · $1,292 in 2025
The $1,292 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $780 · 2023: $1,861 · 2024: $1,150 · 2025: $1,292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,070 · Education: $218 · Travel and Lodging: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,070.04 |
| Education | $218.29 |
| Travel and Lodging | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,695.31 | 2023-2025 | |
| Genzyme Corporation | $942.00 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $529.57 | 2022-2024 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $449.84 | 2023-2024 | Sotyktu |
| Amgen INC. | $278.85 | 2022-2023 | Otezla |
| Galderma Laboratories, L.P. | $247.87 | 2022-2024 | |
| Sun Pharmaceutical Industries INC. | $238.96 | 2022-2024 | Winlevi |
| Revance Therapeutics, INC. | $165.60 | 2024-2025 | Daxxify |
| Almirall LLC | $115.64 | 2023 | Klisyri |
| Janssen Biotech, INC. | $115.21 | 2024 | Tremfya |
| Sanofi-Aventis U.S. LLC | $99.00 | 2023 | |
| Incyte Corporation | $50.23 | 2023-2024 | Opzelura |
| Arcutis Biotherapeutics, INC. | $34.53 | 2023 | |
| Novartis Pharmaceuticals Corporation | $24.53 | 2022 | |
| Journey Medical Corporation | $23.09 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $22.71 | 2023 | |
| Lilly USA, LLC | $19.39 | 2023 | Olumiant, Taltz |
| Leo Pharma INC. | $17.77 | 2023 | Adbry |
| Genentech USA, INC. | $12.98 | 2023 | Erivedge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taehee Strauss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.